Long-term denervation impairs insulin receptor substrate-1-mediated insulin signaling in skeletal muscle

Metabolism: Clinical and Experimental

Volumn 50, Issue 2, 2001, Pages 216-222

  Hirose, Munetaka ^a,b,c   Kaneki, Masao ^a,b,c   Sugita, Hiroki ^a,b,c   Yasuhara, Shingo ^a,b,c   Martyn, J A Jeevendra ^a,b,c   Iebunjo, Chikwendu ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; PROTEIN SUBUNIT; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LONG TERM EXPOSURE; MALE; MOLECULAR INTERACTION; MUSCLE DENERVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0035116139     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.20169     Document Type: Article

References (43)

1. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
2. Differential regulations of insulin receptor substrate-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse
3. Differential role of insulin receptor substrate (IRS)-1 and IRS-2 in L6 skeletal muscle cells expressing the arg1152 → gln insulin receptor
4. Increased insulin sensitivity and hypoglycemia in mice lacking the p85alpha subunit of phosphoinositide 3-kinase
5. Genetic engineering in mice: Impact on insulin signaling and action
6. Phosphoinositide 3-kinase: The key switch mechanism in insulin signaling
7. Insulin resistance of denervated rat muscle: A model for impaired receptor-function coupling
8. In vitro and in vivo activation of the insulin receptor kinase in control and denervated skeletal muscle
9. Dynamics of insulin resistance in denervated slow and fast muscles in vivo
10. Phosphatidylinositol 3-kinase and dynamics of insulin resistance in denervated slow and fast muscles in vivo
11. Akt1 kinase and dynamics of insulin resistance in denervated muscles in vivo
12. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene
13. Insulin receptor substrate-2 is not necessary for insulin- and exercise-stimulated glucose transport in skeletal muscle
14. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
15. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family
16. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family
17. Analysis of thermal injury-induced insulin resistance in rodents
18. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat
19. Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors
20. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM
21. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins
22. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus
23. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse
24. Regulation of insulin-stimulated glucose transport GLUT4 translocation and Akt1 kinase activity by ceramide
25. Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes
26. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1
27. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate
28. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo
29. Tumor necrosis factor alpha inhibits signaling from the insulin receptor
30. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction
31. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function
32. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
33. Surgical denervation increases protein tyrosine phosphatase activity in skeletal muscle
34. Muscle protein turnover and the wasting due to injury and disease
35. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway
36. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats
37. A new twist to myopathy of critical illness
38. DNA-fragmentation and expression of apoptosis-related proteins in experimentally denervated and reinnervated rat facial muscle
39. Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T and B cell deficient mice
40. The 1999 Moyer award. Burn injury induces skeletal muscle apoptosis and the activation of caspase pathways in rats
41. Regulation of ceramide production and apoptosis
42. Apoptosis. Death cycle and Swiss army knives
43. P13K: Downstream AK-Tion blocks apoptosis